Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial
Completed
- Conditions
- Acute Rhinosinusitis
- Interventions
- Device: Nasal spray
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Saffron Pharma
- Target Recruit Count
- 20
- Registration Number
- NCT05639959
- Locations
- 🇵🇰
Saffron Pharmaceutical, Faisalabad, Punjab, Pakistan
News
No news found